throbber
Paper No. __
`Filed: March 31, 2016
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`________________
`
`RANBAXY INC.
`Petitioner,
`
`v.
`
`JAZZ PHARMACEUTICALS, INC. and
`JAZZ PHARMACEUTICALS IRELAND LTD.
`Patent Owner
`
`________________
`
`Case IPR2016-00738
`Patent 9,050,302
`________________
`
`PATENT OWNER MANDATORY NOTICES UNDER
`35 U.S.C. §§ 311-319 AND 37 C.F.R. §§ 42.8, 42.100 ET. SEQ.
`
`
`
`
`
`

`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Case IPR2016-00738
` Patent 9,050,302
`
`
`Patent Owner Mandatory Notices
`
`
`REAL PARTIES-IN-INTEREST
`
`Pursuant to the requirements of 37 C.F.R. § 42.8(b)(1), the undersigned state
`
`that Jazz Pharmaceuticals, Inc. (“Jazz”) and Jazz Pharmaceuticals Ireland Ltd.
`
`(“Jazz Ireland”) are the real parties-in-interest. Jazz is a corporation organized and
`
`existing under the laws of the State of Delaware, having a principal place of
`
`business at 3180 Porter Drive, Palo Alto, California 94304. Jazz Ireland is a
`
`corporation existing under the laws of Ireland, having a principle place of business
`
`at One Burlington Road, Fourth Floor, Connaught House, Dublin, Ireland 4. Jazz
`
`Ireland owns by assignment the entire right, title, and interest in U.S. Patent No.
`
`9,050,302 (the “’302 patent”) by virtue of an Assignment of rights from the
`
`inventor, Mark Eller, to Jazz (Reel/Frame 30652-164), and Assignment of rights
`
`from Jazz to Jazz Ireland (Reel/Frame 33480-135). The Assignments were
`
`recorded with the United States Patent and Trademark Office on May 24, 2013 and
`
`July 29, 2014. Jazz is currently the exclusive licensee of the ’302 patent.
`
`RELATED MATTERS
`
`Pursuant to 37 C.F.R. § 42.8(b)(2), the undersigned state that the ’302 patent
`
`is the subject of six, currently-pending litigations: Jazz Pharmaceuticals, Inc. et al.
`
`v. Amneal Pharmaceuticals, LLC, et al., 2:13-cv-391 (D.N.J.) (consolidated); Jazz
`
`Pharmaceuticals, Inc., et al. v. Roxane Laboratories, Inc., 2:15-cv-1360 (D.N.J.)
`
`
`
`

`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Case IPR2016-00738
` Patent 9,050,302
`
`
`Patent Owner Mandatory Notices
`
`
`(consolidated); Jazz Pharmaceuticals, Inc. et al. v. Watson Laboratories, Inc.,
`
`2:16-cv-1505 (D.N.J.); Jazz Pharmaceuticals, Inc. et al. v. Wockhardt Bio AG et
`
`al., 2:16-cv-99 (D.N.J.); Jazz Pharmaceuticals, Inc. et al. v. Sun Pharmaceutical
`
`Industries Ltd., et al., 2:15-cv-8229 (D.N.J.); Jazz Pharmaceuticals, Inc. et al. v.
`
`Par Pharmaceutical, Inc., 2:15-cv-7580 (D.N.J.); and Jazz Pharmaceuticals, Inc.
`
`et al. v. Amneal Pharmaceuticals, LLC, 2:15-cv-6562 (D.N.J.).
`
`Three other inter partes reviews filed by Par Pharmaceutical, Inc. (IPR2016-
`
`00002), Ranbaxy Inc. (IPR2016-00024) and Amneal Pharmaceuticals LLC
`
`(IPR2016-00546), concern a patent related to the ’302 patent.
`
`Further, PCT/US14/19217, filed on February 28, 2014, and U.S. Application
`
`No. 14/707,914, filed on May 8, 2015, claim the benefit of the ’302 patent.
`
`LEAD COUNSEL AND BACK-UP COUNSEL (37 C.F.R. § 42.8(b)(3))
`
`Lead Counsel:
`
`
`
`F. Dominic Cerrito (Reg. No. 38,100)
`
`Contact Information:
`
`Quinn Emanuel Urquhart & Sullivan, LLP
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`51 Madison Avenue, 22nd Floor
`
`New York, NY 10010
`
`Email: nickcerrito@quinnemanuel.com
`
`Telephone: 212-849-7000
`
`
`
`
`
`
`
`
`
`
`
`

`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Case IPR2016-00738
` Patent 9,050,302
`
`
`Patent Owner Mandatory Notices
`
`
`Back-Up Counsel:
`
`Evangeline Shih (Reg. No. 50,170)
`
`Contact Information:
`
`Quinn Emanuel Urquhart & Sullivan, LLP
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`51 Madison Avenue, 22nd Floor
`
`New York, NY 10010
`
`Email: evangelineshih@quinnemanuel.com
`
`Telephone: 212-849-7000
`
`Back-Up Counsel:
`
`Frank C. Calvosa (Reg. No. 69,064)
`
`Contact Information:
`
`Quinn Emanuel Urquhart & Sullivan, LLP
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`51 Madison Avenue, 22nd Floor
`
`New York, NY 10010
`
`Email: frankcalvosa@quinnemanuel.com
`
`Telephone: 212-849-7000
`
`Back-Up Counsel:
`
`Michael Tuscan (Reg. No. 40,210)
`
`Contact Information:
`
`Cooley LLP
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`1299 Pennsylvania Avenue, NW
`
`Suite 700
`
`Washington, DC 20004
`
`Email: mtuscan@cooley.com
`
`Telephone: 202-842-7802
`
`
`
`
`
`
`
`
`
`
`
`
`
`

`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Case IPR2016-00738
` Patent 9,050,302
`
`
`Patent Owner Mandatory Notices
`
`
`Back-Up Counsel:
`
`Thomas Blinka (Reg. No. 44,541)
`
`Contact Information:
`
`Cooley LLP
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`1299 Pennsylvania Avenue, NW
`
`Suite 700
`
`Washington, DC 20004
`
`Email: tblinka@cooley.com
`
`Telephone: 202-842-7865
`
`
`
`
`
`
`
`
`
`
`
`
`
`SERVICE INFORMATION
`
`Pursuant to 37 C.F.R. § 42.8(b)(4), please direct all correspondence to lead
`
`and back-up counsel at the above addresses. Patent Owner consents to email
`
`service at the above-specified email addresses.
`
`
`
`Date: March 31, 2016
`
`
`
` Respectfully submitted,
`
`By: /F. Dominic Cerrito (Reg. No. 38,100)/
` F. Dominic Cerrito (Reg. No. 38,100)
` Evangeline Shih (Reg. No. 50,170)
` Frank C. Calvosa (Reg. No. 69,064)
`QUINN EMANUEL URQUHART &
`SULLIVAN LLP
`51 Madison Avenue, 22nd Floor
`New York, NY 10010
`Tel: (212) 849-7000
`Fax: (212) 849-7100
`
`

`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Case IPR2016-00738
` Patent 9,050,302
`
`
`Patent Owner Mandatory Notices
`
`
`nickcerrito@quinnemanuel.com
`evangelineshih@quinnemanuel.com
`frankcalvosa@quinnemanuel.com
`
`Michael Tuscan (Reg. No. 40,210)
`Thomas Blinka (Reg. No. 44,541)
`COOLEY LLP
`1299 Pennsylvania Avenue, NW
`Suite 700
`Washington, DC 20004
`Tel: (202) 842-7865
`Fax: (202) 842-7899
`mtuscan@cooley.com
`tblinka@cooley.com
`
`Attorneys for Jazz Pharmaceuticals
`
`
`
`

`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`________________
`
`RANBAXY INC.
`Petitioner,
`
`v.
`
`JAZZ PHARMACEUTICALS, INC. and
`JAZZ PHARMACEUTICAL IRELAND LTD.
`Patent Owner
`
`________________
`
`Case IPR2016-00738
`Patent 9,050,302
`________________
`
`CERTIFICATE OF SERVICE
`
`
`
`
`
`

`
`
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 C.F.R. § 42.6(e), the undersigned hereby certify that
`
`PATENT OWNER MANDATORY NOTICES UNDER 35 U.S.C. §§ 311-319
`
`AND 37 C.F.R. §§ 42.8, 42.100 ET. SEQ. and the attached POWER OF
`
`ATTORNEY and 3.73(b) STATEMENT were served on March 31, 2016 by filing
`
`these documents through the Patent Review Processing System, as well as e-
`
`mailing copies to Joseph.Reisman@knobbe.com, Carol.PitzelCruz@knobbe.com,
`
`Kerry.Taylor@knobbe.com, and BoxRanbaxy332@knobbe.com.
`
`Date: March 31, 2016
`
`
`
` Respectfully submitted,
`
`By: /F. Dominic Cerrito (Reg. No. 38,100)/
` F. Dominic Cerrito (Reg. No. 38,100)
` Evangeline Shih (Reg. No. 50,170)
` Frank C. Calvosa (Reg. No. 69,064)
`QUINN EMANUEL URQUHART &
`SULLIVAN LLP
`51 Madison Avenue, 22nd Floor
`New York, NY 10010
`Tel: (212) 849-7000
`Fax: (212) 849-7100
`nickcerrito@quinnemanuel.com
`evangelineshih@quinnemanuel.com
`frankcalvosa@quinnemanuel.com
`
`Michael Tuscan (Reg. No. 40,210)
`Thomas Blinka (Reg. No. 44,541)
`COOLEY LLP
`1299 Pennsylvania Avenue, NW
`Suite 700
`Washington, DC 20004
`Tel: (202) 842-7865
`Fax: (202) 842-7899
`
`

`
`
`
`mtuscan@cooley.com
`tblinka@cooley.com
`
`Attorneys for Jazz Pharmaceuticals

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket